Expression patterns of plasma von Willebrand factor and serum interleukin—8 in p

时间:2022-10-29 01:45:31

BACKGROUND: von Willebrand factor (vWF) is only released from endothelial cells and platelets and is an in vivo and in vitro marker of endothelial injury in septic patients with acute lung injury (ALI). Interleukin-8 (IL-8), as a proinflammatory mediator causing recruitment of inflammatory cells, induces an increase in oxidant stress mediators and makes it as a key parameter for localized inflammation. However, it has not been well established whether the level of serum IL-8 is associated with the severity of lung injury and whether it is a prognosis marker for severe lung contusion. This study was to investigate the expression of plasma vWF and IL-8 and their association with the severity and outcomes of severe pulmonary contusion.

METHODS: A total of 63 patients were divided into a severe pulmonary contusion with acute respiratory distress syndrome (ARDS) group and a non-ARDS group, or a survivor group and a non-survivor group, or an injury severity score (ISS)

RESULTS: The concentrations of plasma vWF and serum IL-8 were significantly increased in all severe pulmonary contusion patients at all time points in comparison with the control group. The concentrations of plasma vWF in patients with ARDS increased during the whole study period, but vWF in patients with non-ARDS increased gradually until day 5 and then decreased at day 7. The concentration of serum IL-8 showed a similar expression pattern in both groups, but the expression increased more significantly in the ARDS group than in the non-ARDS group. Interestingly, both plasma vWF and serum IL-8 levels steadily increased in the non-survivor group. Furthermore, the level of plasma vWF was higher in the ISS≥20 group than in the ISS

CONCLUSION: The elevated levels of plasma vWF and serum IL-8 in severe pulmonary contusion patients reflect the severity of pulmonary injury and patients outcomes, suggesting that the plasma vWF and serum IL-8 are sensitive markers for clinical evaluation of the severity of pulmonary injury and predication of patient prognosis.

KEY WORDS: Von Willebrand factor; Interleukin-8; Pulmonary contusion

World J Emerg Med 2011;2(2):122-126

INTRODUCTION

Traffic and industrial accidents have been increasing in China due to the rapid development of transportation and industrialization, and these accidents definitely cause multiple traumas each year such as chest wall injury.Severe chest wall trauma is often complicated with severe pulmonary contusion, which is a common cause of acute respiratory distress syndrome (ARDS) and is associated with a high mortality. [1,2] Endothelial injury and inflammation contribute to lung injury.

Von Willebrand factor (vWF) is a blood glycoprotein involving in hemostasis. vWF, a large multimeric glycoprotein present in blood plasma, is produced constitutively in the endothelium (in the Weibel-Palade bodies), megakaryocytes (α-granules of platelets), and subendothelial connective tissue.[2] vWF is only released from endothelial cells and platelets and is an in vivo and in vitro marker of endothelial injury in septic patients with acute lung injury (ALI).[3] Interleukin-8 (IL-8), as a proinflammatory mediator causing recruitment of inflammatory cells, induces an increase in oxidant stress mediators and makes it as a key parameter for localized inflammation.[4] However, it has not been well established whether the level of serum IL-8 is associated with the severity of lung injury and whether it is a prognosis marker for severe lung contusion. In the present study, we investigated the expression of vWF and IL-8 in the first 7 days after trauma and the association of their expressions with clinical data.

METHODS

Clinical data

Altogether 63 patients, 44 males and 19 females, were admitted to the intensive care unit (ICU), First Affiliated Hospital, Suzhou University between April 2008 and May 2010. All patients met the definition of severe pulmonary contusion.[5] The data of the patients included Acute Physiology and Chronic Health Evaluation II (APCHE II), injury severity score (ISS), age, sex, white blood cell count, platelet count, and blood sugar level. Patients were excluded if they showed any evidence of blood diseases, disseminated intravascular coagulation (DIC), history of heart and lung diseases, recent infection and low innate immunity, and admission to hospital more than 24 hours after injury. Injuries included motor vehicle crash (46 patients), high fall (11 patients), pound injury (5 patients), and coup injury (1 patient). Thirty-eight patients had single side pulmonary contusion and 25 had bilateral pulmonary contusion. Forty patients suffered from single-sided multiple rib fracture and 23 suffered from bilateral multiple rib fracture. Among the 63 patients, 47 were complicated with hemopneumothorax, 28 with flail chest, 29 with head injury, 22 with limbs, pelvis or spine fracture, 15 with abdominal injury, and 29 with shock. Twenty-eight out of the 63 patients (19 males and 9 females) met the diagnostic criteria of ARDS [6] with a mean age of 32 ±12.71 years and the rest 35 (25 males and 10 females) were non-ARDS patients with a mean age of 36.34±9.29 years.

The patients were also divided into a survivor (33 males and 12 females) group with a mean age of 35.28±10.12 years and a non-survivor (11 males and 7 females) group with a mean age of 38.02±7.14 years. The ISS scores of 21 patients (16 males and 5 females) with an average age of 29.86±12.17 years were less than 20, and those of 42 patients with an average age of 34.44 ±11.14 years were equal to or more than 20.

In 20 healthy volunteers who served as controls, there were 12 males and 8 females with a mean age of 30.23±8.21 years. There was no significant difference in the clinical treatment of all patients.

Methods

At 1, 3, 5, and 7 days after injury, 4 mL blood was taken from the patients, and 2 mL blood was added into a tube containing anti-coagulant EDTA. The blood sample was centrifuged at 3000 r/min for 10 minutes. Plasma was collected and stored at –70 °C. The rest 2 mL blood was added into a tube without anticoagulant, and left at room temperature for 30 minutes. The sample was centrifuged at 2000 r/min for 15 minutes. Serum was taken and stored at –70 °C. Samples from healthy volunteers were processed by the same procedures. The kit for measuring vWF was purchased from the Blood Institute of Suzhou University. The kit for testing IL-8 was purchased from Genzyme (USA). Plasma vWF and serum IL-8 were measured by ELISA according to the manufacturer's instruction.

Statistical analysis

Data of vWF and IL-8 were presented as mean ±standard deviation. The difference between the groups were analyzed by two-way ANOVA or the chi-square test where appropriate using SPSS13.0 software. The correlation study was analyzed by Spearman's rank-order correlation coefficient.

RESULTS

vWF

The mean vWF level of healthy volunteers was 92.36%±22.47%. The mean vWF level of different patient groups at all time points was 1.7 to 3 fold higher than that of the healthy volunteers (P

Serum IL-8 level

The mean level of IL-8 expression of healthy volunteers was 43.16±7.65 pg/mL. The level in all patient groups was 1.8 to 6.6 fold higher than that of the control group. In the ARDS group, the IL-8 level increased and peaked at the 5th day and declined at the 7th day. The IL-8 expression in the non-ARDS group showed a similar pattern but with a less increased level of expression (Table 2). The IL-8 expression in the non-survivor group again maintained a stead increase like vWF, whereas the expression in the survivor group was always lower than that in the non-survivor group and declined at the 3rd day (Table 2). The IL-8 expression in the ISS score≥20 group was higher than that in the ISS score

Correlation analysis

The plasma vWF expression was positively correlated with platelet count (r=0.618, P

DISCUSSION

Pulmonary contusion is a common pulmonary injury resulted from blunt chest wall injury and often occurs after traffic accident, high fall injury, crush injury, coup injury etc, with a mortality of 10%-25%.[7] About 12% of cases of severe pulmonary contusion caused by chest wall injury have a high mortality from 14% to 40%.[8] Pulmonary contusion is an independent risk factor for ALI and ventilator-associated pneumonia[9,10] and is also a risk factor for ALI patients with poor prognosis.[11]

Endothelial injury promotes platelet aggregation and triggers the coagulation cascade leading to micro vessels thrombosis.[12] It has been reported that endothelial injury may be a major contributor to ALI/ARDS.[13] VWF has been recognized as a biological marker of endothelial injury in patients both at risk and with established ALI/ARDS.[2,14] It was also reported that vWF level was associated with prolonged mechanical ventilation and increased mortality in pediatric patients.[15] Our results demonstrated that vWF increased continuously in severe pulmonary contusion patients with ARDS and maintained at a high level at the 7th day, whereas the vWF expression in the non-ARDS patients decreased at the 7th day. This was consistent with the finding of Ware and colleagues[2] and supported the theory that there was constant endothelial injury in ARDS patients. Other studies also reported an association between vWF and outcomes of ARDS patients. In our study, we found a steady increase in vWF level in the non-survivor patients and ARDS patients, and this indicated that plasma vWF level predicted the severity of pulmonary injury and poor outcomes of the patients. VWF level was not correlated with ISS, indicating that vWF can't predict the degree of multiple injuries. This finding was contradictory to the result of Siemiatkowki's et al[16] that early vWF level was associated with the severity of multiple injury with ISS>35. The reason may be that the selection of patients from our study was different from theirs and we divided patients according to ISS≥20 and ISS

Mechanical injury can induce serial inflammatory reactions, which may directly or indirectly cause pulmonary injury. Pulmonary contusion activates localized and systemic innate immune mechanisms and recruits neutrophils to the injured lung. Neutrophils are involved in the pathogenesis of ALI/ARDS.[17] Chemokines like IL-8 recruit leukocytes to the injured areas. IL-8 has been identified as the main chemotactic factor for neutrophils in lung fluids of patients with ALI/ARDS.[18] A study [19] reported that IL-8 level increased in the serum and bronchoalveolar lavage fluid in patients with pulmonary contusion, and that the serum IL-8 level was correlated with the severity of injury, indicating that IL-8 was involved in inflammation of pulmonary contusion. Serum IL-8 was also an independent risk factor for prediction of prognosis in ALI.[20] In our study, the elevated level of IL-8 was higher in the severe pulmonary contusion patients with ARDS, non-survivor and ISS≥20 groups compared with the non-ARDS group, survivor group and ISS

In conclusion, plasma vWF and serum IL-8 are useful markers for predicting the severity of lung injury and prognosis in severe pulmonary contusion patients, particularly the expression patterns during the first week of the injury. However, the cut-off points for vWF and IL-8 level in severe pulmonary contusion with poor prognosis still require multi-center large-scale studies.

Funding: None.

Ethical approval: Not needed.

Conflicts of interest: No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

Contributors: Qian JX proposed and wrote the main body of the article. All authors contributed to the design and interpretation of the study and to further drafts.

REFERENCES

1 Zhang W, Tsimhoni O, Sivak M, Flannagan MJ. Road safety in China: analysis of current challenges. J Safety Res 2010; 41: 25-30. Epub 2010 Feb 16.

2 Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424.

3 Ware LB, Eisner MD, Thompson BT. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004; 170: 766-772.

4 Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V, et al. Elevated maternal interleukin-8 levels and risk of schizophrenia inoffspring. Am J Psychiatry 2004; 161: 889-895.

5 Prat N, Rongieras F, Voiglio E, Magnan P, Destombe C, Debord E, et al. Intrathoracic pressure impulse predicts pulmonary contusion volume in ballistic blunt thoracic trauma. J Trauma 2010; 69: 749-755.

6 Zhang SF, Lin SX, Gao W, Liu HP, Liu Y, Zhang DH, et al. Report of the consensus conference on diagnostic criteria of ALI/ARDS at high altitudes in Western China. Intensive Care Med 2001; 27: 1539-1546.

7 Hoth JJ, Martin RS, Yoza BK, Wells JD, Meredith JW, McCall CE. Pulmonary contusion primes systemic innate immunity responses. J Trauma 2009; 67: 14.

8 Perna V, Morera R. Prognostic factors in chest traumas: A prospective study of 500 patients. Cir Esp 2010; 87: 165-170.

9 Raghavendran K, Notter RH, Davidson BA, Helinski JD, Kunkel SL, Knight PR. Lung contusion: inflammatory mechanisms and interaction with other injuries. Shock 2009; 32: 122-130.

10 Miller PR, Croce MA, Kilgo PD, Scott J, Fabian TC. Acute respiratory distress syndrome in blunt trauma: identification of independent risk factors. Am Surg 2002; 68: 845-850.

11 Wu J, Sheng L, Wang S, Li Q, Zhang M, Xu S, et al. Analysis of clinical risk factors associated with the prognosis of severe multiple-trauma patients with acute lung injury. J Emerg Med 2009 Jul 20. [Epub ahead of print].

12 James A. Russell genetic of coagulation factors in acute lung injury. Crit Care Med 2003; 31: 243-247.

13 Wang ND, Stevens MH, Doty DB, Hammond EH. Chest trauma: an experimental model for heart and lung contusion. J Trauma 2003; 54: 744-748.

14 Ware LB, Conner ER, Matthay MA. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 2001; 29: 2325-2331.

15 Flori HR, Ware LB, Milet M, Matthay MA. Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med 2007; 8: 96-101.

16 Siemiatkowski A, K?oczko J, Wereszczyńska-Siemiatkowska U, Czaban SL. Effect of severe multiple trauma complicated by acute lung injury on endothelial cell activity. Przegl Lek 2001; 58: 767-771.

17 Hamada N, Maeyama T, Kawaguchi T, Yoshimi M, Fukumoto J, Yamada M, et al. The role of high mobility group box1 in pulmonary fibrosis. Am J Respir Cell Mol Biol 2008; 39: 440-447. Epub 2008 Apr 25.

18 Shamea BD, Zallen GS, Mclotyre BC, Bensard DD, Pulido EJ, Miller SA, et al. Chemokines as mediators of diseases related to surgical conditions. Shock 2000; 14: 1-7.

19 Bauer OT, Monton C, Torres A, Cabello H, Fillela X, Maldonado A, et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000; 55: 46-52.

20 McClintock D, Zhuo H, Wickersham N, Matthay MA, Ware LB. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care 2008; 12: R41.

Received September 10, 2010

Accepted after revision March 19, 2011

上一篇:Early changes of plasma angiopoietin—2 in ... 下一篇:Sepsis and immune response